Financials
- Market Capitalization 2.11 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.64
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1942 | MESO Mesoblast Limited - American Depositary Shares | 16.76 USD | -3.90% | -0.36% | +18.70% | +28.43% | 2.17 B USD | ||
| 1949 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.11 USD | -1.10% | -2.95% | +9.44% | +35.04% | 2.14 B USD | ||
| 1959 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.09 USD | -1.22% | -7.63% | +14.27% | +126.79% | 2.11 B USD | ||
| 1961 | ADMA ADMA Biologics Inc - Common Stock | 9.39 USD | +0.54% | -1.78% | +9.31% | -45.06% | 2.10 B USD |